natgillin/translations-raw huggingface dataset:
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme:
Da bi zmanjšali nevarnost pojava neželenih učinkov, odmerek dosegate postopoma, po priporočilu sledeče sheme dnevnega odmerjanja:
This medicinal product contains sorbitol.
Zdravilo Memantine Merz vsebuje Sorbitol To zdravilo vsebuje sorbitol.
From Week 4 on: The patient should take two 10 mg film-coated tablets (20 mg) per day.
Od 4. tedna dalje: Bolnik naj jemlje dve 10 mg filmsko obloženi tableti (20 mg) na dan.
Blister packs containing either 7, 10, 14 or 20 tablets per blister strip (Alu/PP).
Pretisni trakovi (Alu/PP), ki vsebujejo ali 7, 10, 14 ali 20 tablet .
In order to reduce the risk of undesirable effects the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows:
Da bi zmanjšali pojavnost neželenih učinkov, je potrebno postopno zviševanje odmerka po 5 mg na teden v prvih treh tednih zdravljenja, kot sledi:
The bottle with the mounted pump may only be kept and transported in a vertical position.
Stekleničko z nameščeno črpalko lahko hranimo in prenašamo le v navpičnem položaju.
Your doctor will advise you.
Če vam je zdravnik povedal,
EU/1/12/799/001 EU/1/12/799/002 EU/1/12/799/003 EU/1/12/799/004 EU/1/12/799/005 EU/1/12/799/006 EU/1/12/799/007 EU/1/12/799/008 EU/1/12/799/009 EU/1/12/799/010 EU/1/12/799/011 EU/1/12/799/012
EU/1/12/799/001 EU/1/12/799/002 EU/1/12/799/003 EU/1/12/799/004 EU/1/12/799/005 EU/1/12/799/006 EU/1/12/799/007 EU/1/12/799/008 EU/1/12/799/009 EU/1/12/799/010 EU/1/12/799/011
one and a half 10 mg tablet week 4 and beyond two 10 mg tablets once a day
4. teden in naprej dve 10 mg tableti enkrat dnevno
three pump actuations week 4 and beyond four pump actuations
4. teden in naprej štirje pritiski navzdol
Gait abnormal
Neobičajna hoja
What Memantine Merz looks like and contents of the pack
Izgled zdravila Memantine Merz in vsebina pakiranja
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (20x 42 TABLETS) WRAPPED IN FOIL (INCLUDING BLUE BOX)
ZUNANJA NALEPKA NA VEČKRATNEM PAKIRANJU (20 x 42 TABLET) V FOLIJI (VKLJUČUJOČ "BLUE BOX")
The active substance is memantine hydrochloride.
Zdravilna učinkovina je memantinijev klorid.
The use of medicinal products called amantadine (for the treatment of Parkinson´s disease), ketamine (a substance generally used as an anaesthetic), dextromethorphan (generally used to treat cough) and other NMDA-antagonists at the same time should be avoided.
Potrebno se je izogibati sočasni uporabi zdravil, kot so amantadin (za zdravljenje Parkinsonove bolezni), ketamin (snov, ki se uporablja kot anestetik), dekstrometorfan (splošna uporaba za zdravljenje kašlja) in ostali zaviralci receptorjev NMDA.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
da ne prenašate nekaterih sladkorjev, se posvetujte z njim, preden vzamete to zdravilo.
The recommended daily dose is 20 mg once a day.
Priporočen dnevni odmerek je 20 mg enkrat dnevno.
The maximum daily dose is 20 mg once daily.
Največji dnevni odmerek je 20 mg enkrat dnevno.
How to take Memantine Merz
Kako jemati zdravilo Memantine Merz
Memantine Merz contains the active substance memantine hydrochloride.
Zdravilo Memantine Merz vsebuje zdravilno učinkovino memantinijev klorid.
The recommended dose of Memantine Merz for adults and older people is four pump actuations, equivalent to 20 mg once a day.
Za odrasle in starejše je priporočeni odmerek zdravila Memantine Merz štiri polni pritiski navzdol, kar ustreza 20 mg enkrat dnevno.
EU/1/12/799/013 EU/1/12/799/014 EU/1/12/799/015 EU/1/12/799/016 EU/1/12/799/017 EU/1/12/799/018 EU/1/12/799/019 EU/1/12/799/020 EU/1/12/799/021 EU/1/12/799/022 EU/1/12/799/023 EU/1/12/799/024
EU/1/12/799/013 EU/1/12/799/014 EU/1/12/799/015 EU/1/12/799/016 EU/1/12/799/017 EU/1/12/799/018 EU/1/12/799/019 EU/1/12/799/020 EU/1/12/799/021 EU/1/12/799/022 EU/1/12/799/023
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
A. IZDELOVALECODGOVOREN ZA SPROŠČANJE SERIJE
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg per day.
Pri bolnikih s hudo okvaro delovanja ledvic (očistek kreatinina 5 - 29 ml/min) naj bo dnevni odmerek 10 mg.
From Week 4 on: The patient should take one 20 mg film-coated tablet per day.
Od 4. tedna dalje: Bolnik naj jemlje eno 20 mg filmsko obloženo tableto na dan.
Memantine Merz should be administered orally once a day.
Zdravilo Memantine Merz jemljite peroralno enkrat dnevno.
These compounds act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related may be more frequent or more pronounced (see also section 4.5).
zato so lahko neželeni učinki (zlasti s strani osrednjega živčnega sistema (OŽS) pogostejši in bolj izraženi (glejte tudi poglavje 4.5).
Pack sizes of 14, 28, 42, 56, 98 or multipacks containing 840 (20 x 42) film-coated tablets are presented.
Na voljo so pakiranja s 14, 28, 42, 56, 98 filmsko obloženimi tabletami in večkratna pakiranja z 840 (20 x 42) filmsko obloženimi tabletami.
The bottle should be placed on a flat, horizontal surface, for example a table top, and only use it in a vertical position.. A glass with a little water or a spoon should be hold below the nozzle and the dosing pump head has to be pushed down in a firm but calm and steady manner (not too slowly) right down to the stop (fig. 7, fig. 8).
Pod cevnim izvodilom pridržimo kozarec z malo vode ali žlico; odmerno črpalko pritiskamo navzdol odločno, a mirno in enekomerno (ne prepočasi), vse dokler se ne zaustavi
The recommended dose of Memantine Merz for adults and older people is 20 mg once a day.
Za odrasle in starejše je priporočeni odmerek zdravila Memantine Merz 20 mg enkrat dnevno.
The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, and magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171) and iron oxide yellow (E 172) all in the tablet coating.
Pomožne snovi so: mikrokristalna celuloza, premrežen natrijev karmelozat,brezvoden koloidni silicijev dioksid in magnezijev stearat, vse v jedru tablete; in hipermeloza, makrogol 400, titanov dioksid (E 171) in rumeni železov oksid (E 172), vse v oblogi tablete.
Also, Memantine Merz may change your reactivity, making driving or operating machinery inappropriate.
Prav tako Memantine Merz lahko vpliva na vašo sposobnost odzivanja, zato se vožnja in upravljanje s stroji ne priporoča.
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg tablets
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg filmsko obložene tablete
From Week 4 on: The patient should take 2 ml solution (20 mg) equivalent to four pump actuations once a day.
Od 4. tedna dalje: Bolnik mora jemati 2 ml raztopine (20 mg) na dan, kar ustreza štirim pritiskom navzdol.
In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) daily dose should be 10 mg (1 ml solution, equivalent to two pump actuations).
Pri bolnikih z zmerno okvaro delovanja ledvic (očistek kreatinina 30-49 ml/min) naj bo dnevni odmerek 10 mg (1 ml raztopine, kar ustreza dvema pritiskoma navzdol).
The usual starting dose is one pump actuation (1 x 5 mg) once daily for the first week.
Običajni začetni odmerek je en pritisk navzdol enkrat dnevno (1 x 5 mg) v prvem tednu.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician's interview based impression of change (CIBIC-plus): p=0.025; Alzheimer´s disease cooperative study- activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).
State Examination«)) ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice Vtis sprememb na osnovi kliničnega intervjuja (CIBIC-plus oz. »Clinician's Interview-Based Impression of Change Plus Caregiver Input«): p=0,025; Vprašalnik vsakodnevnih aktivnosti (ADCS-ADLsev) (»Alzheimer's Disease Consortium Studies Activities of Daily Living-modified for severe dementia«): p=0,003; Baterije za hudo prizadetost (SIB oz. »Severe Impairment Battery«): p=0,002).
In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) daily dose should be 10 mg per day.
Pri bolnikih z zmerno okvaro delovanja ledvic (očistek kreatinina 30 - 49 ml/min) naj bo dnevni odmerek 10 mg.
No genotoxicity has been observed following testing of memantine in standard assays.
V standardnih poskusih niso opazili genotoksičnosti.
EU/1/12/799/010 840 film-coated tablets (20 packs of 42) EU/1/12/799/011 980 film-coated tablets (10 packs of 98) EU/1/12/799/012 1000 film-coated tablets (20 packs of 50)
EU/1/12/799/010 840 filmsko obloženih tablet (20 x 42) EU/1/12/799/011 980 filmsko obloženih tablet (10 x 98) EU/1/12/799/012 1000 filmsko obloženih tablet (20 x 50)
The solution should be taken with a little water.
Raztopino pogoltnite z nekaj vode.
No adverse effects of memantine were noted on non-clinical male and female fertility studies.
V nekliničnih študijah plodnosti pri samcih in samicah ni bilo opaziti nobenih neželenih učinkov memantina.
The dosing pump head has two positions and is easy to turn: anticlockwise to unlock and clockwise to lock.
Uporaba odmerne črpalke za odmerjanje: Glava odmerne črpalke ima dva položaja in jo zlahka obračamo - v obratni smeri urnega kazalca
There was no evidence of any carcinogenicity in life long studies in mice and rats.
V študijah na miših in podganah, ki so potekale celo življenjsko dobo, niso opazili karcinogenosti.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 42 tablets, 56 tablets, 98 tablets or in multipacks of 840 (20 x 42) tablets.
Memantine Merz filmsko obložene tablete se nahajajo v pretisnih omotih v škatlicah s 14 tabletami, 28 tabletami, 42 tabletami, 56 tabletami, 98 tabletami.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day as described above.
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan, kot je opisano zgoraj.
Titanium dioxide (E 171) Iron oxide yellow (E 172)
Obloga tablete hipromeloza makrogol 400 titanov dioksid (E 171) rumeni železov oksid (E 172)
EU/1/12/799/001 14 film-coated tablets EU/1/12/799/002 28 film-coated tablets EU/1/12/799/003 30 film-coated tablets EU/1/12/799/004 42 film-coated tablets EU/1/12/799/005 50 film-coated tablets EU/1/12/799/006 56 film-coated tablets EU/1/12/799/007 98 film-coated tablets EU/1/12/799/008 100 film-coated tablets EU/1/12/799/009 112 film-coated tablets
EU/1/12/799/001 14 filmsko obloženih tablet EU/1/12/799/002 28 filmsko obloženih tablet EU/1/12/799/003 30 filmsko obloženih tablet EU/1/12/799/004 42 filmsko obloženih tablet EU/1/12/799/005 50 filmsko obloženih tablet EU/1/12/799/006 56 filmsko obloženih tablet EU/1/12/799/007 98 filmsko obloženih tablet EU/1/12/799/008 100 filmsko obloženih tablet EU/1/12/799/009 112 filmsko obloženih tablet
A pivotal monotherapy study of memantine in the treatment of mild to moderate Alzheimer's disease (MMSE total scores at baseline of 10 to 22) included 403 patients.
Alzheimerjevo boleznijo (skupna ocena ob vključitvi 10 do 22 točk na KPSS) je zajela 403 bolnike.
Week 2 (day 8-14): The patient should take 1 ml solution (10 mg) equivalent to two pump actuations per day for 7 days.
2. teden (8.-14. dan): Bolnik mora sedem dni jemati 1 ml raztopine (10 mg) na dan, kar ustreza dvema pritiskoma navzdol.
EU/1/12/799/013 14 film-coated tablets EU/1/12/799/014 28 film-coated tablets EU/1/12/799/015 42 film-coated tablets EU/1/12/799/016 56 film-coated tablets EU/1/12/799/017 98 film-coated tablets EU/1/12/799/019 14 film-coated tablets EU/1/12/799/020 28 film-coated tablets EU/1/12/799/021 42 film-coated tablets EU/1/12/799/022 56 film-coated tablets EU/1/12/799/023 98 film-coated tablets
EU/1/12/799/013 14 filmsko obloženih tablet EU/1/12/799/014 28 filmsko obloženih tablet EU/1/12/799/015 42 filmsko obloženih tablet EU/1/12/799/016 56 filmsko obloženih tablet EU/1/12/799/017 98 filmsko obloženih tablet EU/1/12/799/019 14 filmsko obloženih tablet EU/1/12/799/020 28 filmsko obloženih tablet EU/1/12/799/021 42 filmsko obloženih tablet EU/1/12/799/022 56 filmsko obloženih tablet EU/1/12/799/023 98 filmsko obloženih tablet
Always take Memantine Merz exactly as your doctor has told you.
Jemljite zdravilo Memantine Merz tako dolgo, kot vam.
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg film-coated tablets Memantine hydrochloride
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg filmsko obložene tablete memantinijev klorid
In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination and gait disturbance) and/or gastrointestinal origin (vomiting and diarrhoea).
Pri prekomernem odmerjanju do 140 mg ali pri neznanih odmerkih so se pri bolnikih pokazali simptomi povezani s centralnim živčnim sistemom (zmedenost, dremavost, zaspanost, vrtoglavica,
Maintenance dose The recommended maintenance dose is 20 mg per day.
Priporočeni vzdrževalni odmerek je 20 mg na dan.
Week 2 (day 8-14): Take one 10 mg tablet once a day (pale yellow to yellow, oval shaped) for 7 days.
2. teden (8.-14. dan): Eno 10 mg filmsko obloženo tableto na dan (bledo rumena do rumena, ovalna) jemljite 7 dni.
Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer's disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 last observation carried forward (LOCF).
Pri bolnikih, zdravljenih z memantinom, se je pokazal statistično značilno boljši učinek kot pri bolnikih, ki so prejemali placebo pri primarnih ciljih študije: lestvica ocene Alzheimerjeve bolezni (ADAS-cog) (p=0,003) in CIBIC-plus (p=0,004) po 24 tednih prenosa zadnjih opaženih rezultatov naprej (LOCF).
One pump actuation contains 5mg memantine hydrochloride.
En pritisk navzdol vsebuje 5 mg memantinijevega klorida.
The next time the dosing pump head is pushed downwards completely (equivalent to one pump actuation), it dispenses the correct dose (fig. 6).
(enako 1 pritisku), bo ta oddelila pravilen odmerek (sl. 6).
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (10 x 50 ml) WRAPPED IN FOIL (INCLUDING BLUE BOX)
ZUNANJA NALEPKA NA VEČKRATNEM PAKIRANJU (10 x 50 ml) V FOLIJI
5 mg tablet week 2
5 mg tableta
The next time the dosing pump head is pushed downwards completely (equivalent to one pump actuation), it dispenses the correct dose (1 pump actuation is equivalent to 0.5 ml oral solution, and contains 5 mg of the active substance memantine hydrochloride; fig. 6).
(enako 1 pritisku), bo ta oddelila pravilen odmerek (1 pritisk ustreza 0.5 ml peroralne raztopine in vsebuje približno 5 mg aktivne učinkovine memantinijevega klorida; sl. 6).
Week 1 (day 1-7): The patient should take 0.5 ml solution (5 mg) equivalent to one pump actuation per day for 7 days.
1. teden (1.-7. dan): Bolnik mora sedem dni jemati 0.5 ml raztopine (5 mg) na dan, kar ustreza enemu pritisku navzdol.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 50 tablets, 56 tablets, 98 tablets, 100 tablets, 112 tablets and multipscks of 840 (20 packs of 42) tablets, 980 (10 packs of 98) tablets or 1000 (20 packs of 50) tablets.
Memantine Merz filmsko obložene tablete se nahajajo v pretisnih omotih v škatlicah s 14 tabletami, 28 tabletami, 30 tabletami, 42 tabletami, 50 tabletami, 56 tabletami, 98 tabletami, 100 tabletami, 112 tabletami.
In another monotherapy study in mild to moderate Alzheimer's disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised.
Pri drugi študiji zdravljenja v monoterapiji pri blagi do zmerni Alzheimerjevi bolezni (skupna ocena KPSS ob vključitvi 11 do 23), v katero je bilo zajeto 470 bolnikov, so bili bolniki randomizirani.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (2 ml solution, equivalent to four pump actuations) as described above.
Na podlagi kliničnih študij je priporočeni odmerek za bolnike nad 65 let starosti 20 mg na dan (2 ml raztopine, kar ustreza štirim pritiskom navzdol), kot je opisano zgoraj.
Take the screw cap off the bottle: The cap must be turned anticlockwise, unscrewed completely and removed (fig. 1).
Zaporko obračamo v obratni smeri urnega kazalca, jo do konca odvijemo in odstranimo (sl. 1).
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR BLISTER PACK
PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA PRETISNI OMOT
Seizures
Bruhanje
Do not use Memantine Merz after the expiry date which is stated on the carton and the bottle label after the EXP.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki na steklenički poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Week 3 (day 15-21): The patient should take one and a half 10 mg film-coated tablet (15 mg) per day for 7 days.
3. teden (15.-21. dan): Bolnik naj sedem dni jemlje eno in pol 10 mg filmsko obloženo tableto (15 mg) na dan.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg tablets once a day) as described above.
Na podlagi kliničnih študij je priporočen odmerek za bolnike nad 65 let starosti 20 mg na dan (dve tableti enkrat dnevno), kot je opisano zgoraj.
How to store Memantine Merz
Shranjevanje zdravila Memantine Merz
Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer´s disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 last observation carried forward (LOCF).
Pri bolnikih, zdravljenih z memantinom, se je pokazal statistično značilno boljši učinek kot pri bolnikih, ki so prejemali placebo pri primarnih ciljih študije: Lestvica ocene Alzheimerjeve bolezni (ADAS-cog) (p=0,003) in prenosa zadnjega opaženega rezultata naprej (CIBIC-plus) (p=0,004) po 24 tednih (LOCF).
Week 3 (day 15-21): Take one 15 mg tablet once a day (grey-orange, oval-oblong) for 7 days.
3. teden (15.-21. dan): Eno 15 mg filmsko obloženo tableto na dan (sivo oranžna, ovalna in podolgovata) jemljite 7 dni.
1 g of solution contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine.
1 gram raztopine vsebuje 10 mg memantinijevega klorida, kar ustreza 8,31 mg memantina.
Memantine Merz acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
in izboljša prenos živčnih signalov in spomin.
Each film-coated tablet contains 5 mg of memantine hydrochloride equivalent to 4.15 mg memantine.
Vsaka filmsko obložena tableta vsebuje 5 mg memantinijevega klorida, kar ustreza 4,15 mg memantina.
Week 1 (day 1-7): Take one 5 mg tablet once a day (white to off-white, oval-oblong) for 7 days.
1. teden (1.-7. dan): Eno 5 mg filmsko obloženo tableto na dan (bela do belkasta, ovalna in podolgovata) jemljite 7 dni.
Titanium dioxide (E 171) Iron oxide yellow and red (E 172)
Rumeni in rdeči železov oksid (E 172)
The 15 mg film-coated tablets are orange to grey-orange, oval-oblong film-coated tablets with imprint ‘15' on one side and imprint ‘MEM' on the other side.
15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalno podolgovate, filmsko obložene tablete z vtisnjeno številko "15" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
The recommended treatment dose of 20 mg per day is achieved by a gradual increase of the Memantine Merz dose during the first 3 weeks of treatment.
Priporočeni zdravilni odmerek 20 mg na dan se doseže s postopnim povečevanjem odmerka zdravila
Memantine Merz 5mg Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg film-coated tablets
Memantine Merz 5 mg Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg filmsko obložene tablete
Memantine was not teratogenic in rats and rabbits, even at maternally toxic doses, and no adverse effects of memantine were noted on fertility.
Memantin ni bil teratogen pri podganah in zajcih,
The 20 mg film-coated tablets are pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20' on one side and imprint ‘MEM' on the other side.
20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalno podolgovate, filmsko obložene tablete z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Memantine Merz 15 mg film-coated tablets are presented as orange to grey-orange, oval-oblong with imprint ‘15' on one side and imprint ‘MEM' on the other side.
Memantine Merz 15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalne in podolgovate z vtisnjeno številko "15" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Week 2 (day 8-14): The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days.
2. teden (8.-14. dan): Bolnik naj sedem dni jemlje eno 10 mg na dan filmsko obloženo tableto (10 mg) na dan.
A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients.
V temeljni klinični študiji pri skupini 252 bolnikov z zmerno do hudo Alzheimerjevo boleznijo (3-14 točk na lestvici Kratkega preskusa spoznavnih sposobnosti (KPSS oz. MMSE »Mini-mental
Week 1 (day 1-7): The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days.
1. teden (1.-7. dan): Bolnik naj sedem dni jemlje polovico 10 mg filmsko obložene tablete (5 mg) na dan.
- if you are allergic (hypersensitive) to memantine hydrochloride or any of the other ingredients of Memantine Merz tablets (listed in section 6).
- če ste alergični na (preobčutljivi za) memantinijev klorid ali katero koli sestavino tablet
CARTON AND LABEL FOR BOTTLE
PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA IN NALEPKA ZA STEKLENICO
Memantine Merz 20 mg film-coated tablets
Memantine Merz 20 mg filmsko obložene tablete
Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine.
Vsaka filmsko obložena tableta vsebuje 10 mg memantinijevega klorida, kar ustreza 8,31 mg memantina.
The 5 mg film-coated tablets are white to off-white, oval-oblong film-coated tablets with imprint ‘5' on one side and imprint ‘MEM' on the other side.
5 mg filmsko obložene tablete so bele do belkaste, ovalno podolgovate, filmsko obložene tablete z vtisnjeno številko "5" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Memantine Merz 20 mg film-coated tablets are presented as are pale red to grey-red, oval-oblong with imprint ‘20' on one side and imprint ‘MEM' on the other side.
Memantine Merz 20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalne in podolgovate z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Drug hypersensitivity
Preobčutljivost za zdravilo
Each film-coated tablet contains 15 mg of memantine hydrochloride equivalent to 12.46 mg memantine.
Vsaka filmsko obložena tableta vsebuje 15 mg memantinijevega klorida, kar ustreza 12,46 mg memantina.
Memantine Merz 15 mg 7 film-coated tablets.
Memantine Merz 15 mg 7 filmsko obloženih tablet.
Memantine Merz 5 mg 7 film-coated tablets.
Memantine Merz 5 mg 7 filmsko obloženih tablet.